As part of an ongoing series of answers to common questions received by the Basser Center, Executive Director Susan Domchek, MD, discusses different types of hereditary breast cancer.
 

Basser Young Leadership Council co-chair Suzanne Zuppello, a freelance writer in New York City, shares her personal story about her BRCA mutation and her decision to freeze her eggs.

Basser Young Leadership Council member Shannon Pulaski, an attorney, wife, and mother, writes about preventative care and the power of support.

Penn Medicine's Ann L. Steiner, MD, an obstetrician-gynecologist and clinical professor, discusses what you need to know about surgical menopause.

Basser Young Leadership Council member Katrina Wells, a BRCA mutation carrier, shares her personal story with how she is managing her ovarian cancer risk.

Basser Center genetic counselor Jackie Powers, MS, LCGC, writes about how to approach preventative surgery and how she counsels patients considering mastectomies to reduce cancer risk.

Payal Shah, MD, a medical oncologist and clinical researcher with the Basser Center and the University of Pennsylvania, writes about how to manage BRCA-associated breast cancer risk and how best to decide between surgery and surveillance. 

Kim Reiss Binder, MD, a medical oncologist and clinical researcher with the Basser Center and the University of Pennsylvania, explains ongoing trials and recent advancements related to BRCA-related pancreatic cancer.

Basser Center genetic counselor Jessica Ebrahimzadeh, MS, LCGC, gives advice about how to discuss health history and cancer risk with your family. 

Kara Maxwell, MD, PhD, a physician scientist with the Basser Center and University of Pennsylvania, discusses hereditary prostate cancer and recent scientific advancements.

Basser Center genetic counselor Danielle McKenna, MS, LCGC, explains what age at which at-risk individuals should consider testing for a BRCA mutation.

In light of a recent news article, the Basser Center stresses that it is extremely rare that genetic testing reports change an interpretation from harmful to anything less than that. If you have been told that you have a BRCA mutation, it is exceedingly unlikely that anything has changed.

As part of an ongoing series of answers to common questions received by the Basser Center, Executive Director Susan Domchek, MD, discusses PARP inhibitors and ways in which they might be combined with other cancer treatments.

Basser Center genetic counselor Jessica M. Long, MS, LCGC, explains the ins and outs of direct-to-consumer genetic testing for hereditary cancer risk.

Roger Greenberg, MD, PhD, the Basser Center’s Director of Basic Science and the Director of the new Penn Center for Genome Integrity, discusses the new Center and how its research will apply to hereditary cancer and more.

Dana Donofree, designer and founder of AnaOno Intimages, shares her own experience with cancer and discusses how to navigate sexual health and intimacy after surgery.

Jessica M. Long, MS, LCGC, a genetic counselor at the Basser Center, writes about the importance of genetic counseling, potential obstacles to meeting a counselor in person, and remote options.